Publication

Article

Oncology & Biotech News

July 2015
Volume9
Issue 7

Tradition of Greatness Continues With 3rd Annual Giants Class

Author(s):

It has been our privilege to salute those who have contributed so richly to the remarkable ongoing progress in oncology.

OncLive Chairman,

Mike Hennessy

Three years ago, the Intellisphere Oncology Specialty Group launched the Giants of Cancer Care® program to recognize the contributions of oncology leaders whose efforts have truly advanced the care of patients with cancer. It has been our privilege to salute those who have contributed so richly to the remarkable ongoing progress in oncology.

The inaugural Giants class recognized the accomplishments of 12 luminaries in the field, with 16 recipients being honored in the second year. This year, the Giants family welcomed another 12 remarkable members at a ceremony in Chicago on May 29.

This year’s Giants are a dynamic and diverse group, each taking a unique path to the pinnacle of the field. The 2015 award winners were recognized in Breast Cancer, Community Outreach/Education, Gastrointestinal Cancer, Genitourinary Cancer, Gynecologic Malignancies, Immuno-Oncology, Lymphoid Neoplasms, Lung Cancer, Melanoma, Myeloid Neoplasms, Scientific Advances, and Supportive/Palliative Care.

A critical component of the Giants program is that the winners are selected by their peers. After an open nomination process, the final voting is conducted by the Giants of Cancer Care selection committee, an advisory panel comprising 28 esteemed oncologists.

Giants of Cancer Care are individuals who propel the field forward, establishing the building blocks for future advances. Thus, it is critical that the Giants be selected by those individuals who are inspired by their work and are following the trail that they have blazed. As the Isaac Newton quote says, “If I have seen further than others, it is by standing upon the shoulders of giants.” It is in this spirit that our Giants coverage this month includes not only the accomplishments of this year’s winners, but also peer testimonials recognizing the inspirational work.

And so, please join us in honoring and celebrating this year’s Giants. The celebration will continue beyond this issue with more detailed profiles of award winners in future editions. For additional coverage of the 2015 Giants and all of the previous winners, go to https://www.giantsofcancercare.com. As always, thank you for reading.

Related Videos
Andrew Ip, MD
Mansi R. Shah, MD
Elizabeth Buchbinder, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Alec Watson, MD
3 experts are featured in this series.
Sangeetha Venugopal, MD, MS, discusses factors that inform JAK inhibitor selection in myelofibrosis.
Grzegorz S. Nowakowski, MD, and Samuel Yamshon, MD, break down the current treatment landscape for relapsed/refractory follicular lymphoma.
2 experts in this video